Targeting dendritic cells with antigen via dendritic cell-associated promoters
Véronique Moulin(Centre hospitalier universitaire de Québec), Gosse J. Adema(Radboud University Nijmegen), Mary E. Morgan(Sunnybrook Health Science Centre), René A. J. Janssen(Dutch Institute for Fundamental Energy Research), Carl G. Figdor(Radboud University Nijmegen), Bas Jansen(Radboud University Nijmegen), E Wielders(Radboud University Nijmegen), Dagmar Eleveld-Trancikova(Radboud University Nijmegen), Maaike W.G. Looman(Radboud University Nijmegen), John B.A.G. Haanen(Leiden University Medical Center)
Cited by 19
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Difference gel electrophoresis. A single gel method for detecting changes in protein extracts
|Electrophoresis|1997|2.2k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k